hydroxyindoleacetic acid has been researched along with mercaptopurine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asaba, H; Deguchi, T; Hosoya, K; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T | 1 |
Dhondt, JL; Guilhot, F; Ingrand, P; Mazingue, F; Mechinaud, F; Millot, F | 1 |
Ikarashi, Y; Ishimaru, H; Kishi, E; Maruyama, Y; Takahashi, A | 1 |
1 trial(s) available for hydroxyindoleacetic acid and mercaptopurine
Article | Year |
---|---|
Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biogenic Amines; Biopterins; Brain Chemistry; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytarabine; Dihydropteridine Reductase; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infusions, Intravenous; Male; Mercaptopurine; Methotrexate; Nerve Tissue Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies | 1995 |
2 other study(ies) available for hydroxyindoleacetic acid and mercaptopurine
Article | Year |
---|---|
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
Topics: Animals; Antimetabolites; Biological Transport; Blood-Brain Barrier; Brain; Capillaries; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Endothelium, Vascular; GABA Agonists; Homovanillic Acid; Indican; Male; Microinjections; Neurotransmitter Agents; Oocytes; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uremia; Xenopus laevis | 2002 |
Development of obesity and neurochemical backing in aurothioglucose-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Aurothioglucose; Brain Chemistry; Cytarabine; Daunorubicin; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mercaptopurine; Mice; Norepinephrine; Obesity; Paraventricular Hypothalamic Nucleus; Prednisolone; Proto-Oncogene Proteins c-fos; Serotonin; Solitary Nucleus; Ventromedial Hypothalamic Nucleus; Vincristine | 2001 |